Biden administration vaccine drive leader David Kessler to step down
Reuters
Published Jan 13, 2023 03:37PM ET
Updated Jan 13, 2023 07:56PM ET
(Reuters) - David Kessler, who led the COVID-19 vaccine distribution efforts for the United States, is stepping down from President Joe Biden's administration, the Department of Health and Human Services confirmed on Friday.
Kessler, a pediatrician and lawyer who headed the U.S. Food and Drug Administration under presidents George H.W. Bush and Bill Clinton, will return to teaching at the University of California, San Francisco, the New York Times reported earlier.
Kessler could not be immediately reached for comment.
The 71-year-old's departure reflects the changing strategy of the Biden administration to shift COVID-19 vaccines to the commercial market from a government-run effort. The former FDA commissioner was chosen to help lead the U.S. COVID-19 vaccine program Operation Warp Speed in January 2021.
As head of the FDA, Kessler cut the time needed to approve drugs to treat AIDS and moved to try to regulate the tobacco industry. He also served as a co-chair of Biden's advisory board on the pandemic.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.